July 1st, 2010
Podcast 94: What does a new meta-analysis tell us about statins and primary prevention?
Audio Player
Podcast: Play in new window | Download
Subscribe: RSS
A meta-analysis of 11 studies encompassing more than 60,000 subjects finds that statins don’t lower all-cause mortality in people without cardiovascular disease. One editorialist calls the study, just published in the Archives of Internal Medicine, “the cleanest and most complete meta-analysis of pharmacological lipid lowering for primary prevention.”
One of the study’s principal authors, Kausik K. Ray, talked with us from London. I think you’ll find that listening in is worth your time.
Interview-related links:
News-related links:
- Starting dialysis early doesn’t improve mortality
- Digoxin’s dangers in dialysis
- Rosiglitazone’s bad week
- Tight glucose control in diabetes brings some benefits, but at the cost of “imprudent” risks
- PSA testing for prostate cancer lowers mortality, but mostly in low-screening regions
Categories: Audio, Cardiovascular risk, statins, Uncategorized
Tags: Cardiovascular risk, chronic kidney disease, diabetes, digoxin, hemodialysis, hemoglobin A1c, Jupiter study, Kausik K. Ray, meta-analysis, prevention, prostate screening, PSA, rosiglitazone, statins
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
Comments are closed.
About the Podcast
Comments, suggestions, and story ideas welcome. Learn more about Clinical Conversations.
Follow us:
Subscribe to Clinical Conversations via Email
Archives
-
Recent Posts
- Podcast 298: COPD exacerbations — 7 days of antibiotics versus 2
- Podcast 301: Monkeypox — what to look for, how to treat
- Podcast 300: NADIM II trial offers “quite exciting” results in lung cancer
- Podcast 299: Lung cancer and atezolizumab — results from the IMpower010 trial
- Podcast 297: Forget about all that vitamin D testing!!
- Podcast 296: A roundtable on the question, Why are young internists flocking to the hospitalist practice style?
- Podcast 295: How should clinicians manage severe (but asymptomatic) carotid artery stenosis while awaiting CREST-2’s results?
- Podcast 294: PD-1 blockade in locally advanced rectal cancer
- Podcast 293: HER2-“low” breast cancer and its reponse to an antibody-drug conjugate
- Podcast 292: Informed consent and apnea testing for death — or — What is death, anyway?
-
Tag Cloud
- 2009 H1N1 acute coronary syndromes aspirin asthma blood pressure breast cancer cancer risk cardiovascular disease Cardiovascular risk COPD coronary heart disease dabigatran dementia depression diabetes Diabetes type 2 diet Elderly Emergency medicine epidemiology falls FDA glucose guidelines H1N1 Heart failure hypertension influenza pain Patient care patients pregnancy Prostate cancer prostate screening proton pump inhibitors PSA Quality of care risk Rivaroxaban screening smoking stents stroke vaccination warfarin